These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1149019)

  • 1. Changes of the immunogenic properties of a radiation-induced mouse lymphoma following treatment with antitumor drugs.
    Bonmassar E; Testorelli C; Franco P; Goldin A; Cudkowicz G
    Cancer Res; 1975 Aug; 35(8):1957-62. PubMed ID: 1149019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-mediated immunogenic changes of virus-induced leukemia in vivo.
    Houchens DP; Bonmassar E; Gaston MR; Kende M; Goldin A
    Cancer Res; 1976 Apr; 36(4):1347-52. PubMed ID: 1260759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effects of host antitumor immune responses and chemotherapy. Studies with hexamethylmelamine.
    Tricarico M; Fuschiotti P; Ricci F; De Filippi R; Nunziata C; Pastore S; De Vecchis L
    Chemioterapia; 1988 Jun; 7(3):203-7. PubMed ID: 3139307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune inhibition of allogeneic lymphoma cells in the peritoneal cavity of mice.
    Fioretti MC; Libarati M; Bonmassar E; Cudkowicz G
    Cancer Res; 1975 Jan; 35(1):30-6. PubMed ID: 1089042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
    Chen PW; Kaba DS; Ananthaswamy HN
    Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased immunogenicity of murine lymphoma cells following exposure to gamma rays in vivo.
    Guadagni F; Roselli M; Fuggetta MP; Perno CF; Goldin A; Giuliani A
    Chemioterapia; 1984 Dec; 3(6):358-64. PubMed ID: 6529777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assay.
    Fuji H; Mihich E
    Cancer Res; 1975 Apr; 35(4):946-52. PubMed ID: 1090366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade.
    Hines DL
    Cancer Res; 1986 Oct; 46(10):4921-6. PubMed ID: 3489516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturally occurring leukemia viruses in H-2 congenic C57BL mice. I. High lymphoma incidence following milk-borne transmission of virus.
    Melief CJ; Vlug A; de Goede RE; de Bruyne C; Barendsen W; de Greeve P
    J Natl Cancer Inst; 1980 May; 64(5):1179-89. PubMed ID: 6245301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation resistance of drug-treated allogeneic mice against murine lymphomas--II. Studies with various tumor-host combinations.
    Bonmassar A; Rivosecchi-Merletti P; Barzi A; Goldin A; Bonmassar E
    Int J Immunopharmacol; 1981; 3(4):391-9. PubMed ID: 7333720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-mediated increase of tumor immunogenicity in vivo for a new approach to experimental cancer immunotherapy.
    Giampietri A; Bonmassar A; Puccetti P; Circolo A; Goldin A; Bonmassar E
    Cancer Res; 1981 Feb; 41(2):681-7. PubMed ID: 7448813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonimmunogenic radiation-induced lymphoma: immunity induction by a somatic cell hybrid.
    Yefenof E; Goldapfel M; Ber R
    J Natl Cancer Inst; 1982 May; 68(5):841-9. PubMed ID: 6951093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
    Roberts LK
    J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenic potential of tumor cells after treatment with antitumor chemotherapeutic agents.
    Ujiie T
    Jpn J Exp Med; 1988 Feb; 58(1):33-8. PubMed ID: 2454340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of allogeneic lymphomas in spleens of irradiated mice: importance of the D end of the H-2 complex.
    Bonmassar E; Cudkowicz G
    J Immunol; 1976 Aug; 117(2):697-700. PubMed ID: 781136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro generation of a highly immunogenic subline of L1210 leukemia following exposure to 5-(3,3'-dimethyl-1-triazeno)imidazole-4-carboxamide.
    Contessa AR; Bonmassar A; Giampietri A; Circolo A; Goldin A; Fioretti MC
    Cancer Res; 1981 Jun; 41(6):2476-82. PubMed ID: 7016315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.
    Heppner GH; Dexter DL; DeNucci T; Miller FR; Calabresi P
    Cancer Res; 1978 Nov; 38(11 Pt 1):3758-63. PubMed ID: 698935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host endocrine responses during tumor growth.
    Besedovsky H; del Rey A; Normann SJ
    Prog Clin Biol Res; 1989; 288():203-13. PubMed ID: 2654951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of allogeneic tumor transplants: induced rejection of advanced tumors by immune alteration of recipients.
    Russell PS; Chase CM; Burton RC
    J Immunol; 1983 Feb; 130(2):951-7. PubMed ID: 6336775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
    Naito K; Pellis NR; Kahan BD
    Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.